Validation and Genomic Interrogation of the MET Variant rs11762213 as a Predictor of Adverse Outcomes in Clear Cell Renal Cell Carcinoma

BACKGROUND: The exonic single nucleotide variant rs11762213 located in the MET oncogene has recently been identified as a prognostic marker in clear cell renal cell carcinoma (ccRCC). We validated this finding using the Cancer Genome Atlas cohort and explored the biologic implications. METHODS: Geno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Hakimi, A. Ari, Ostrovnaya, Irina, Jacobsen, Anders, Susztak, Katalin, Coleman, Jonathan A., Russo, Paul, Winer, Andrew G., Mano, Roy, Sankin, Alexander I., Motzer, Robert J., Voss, Martin H., Offit, Kenneth, Purdue, Mark, Pomerantz, Mark, Freedman, Matthew, Choueiri, Toni K., Hsieh, James J., Klein, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4803437/
https://ncbi.nlm.nih.gov/pubmed/26505625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados